Anavex Life Sciences Corp (AVXL)

[Investor2014]

To judge the merits of that idea we need to understand what exactly the mythological issue are that made CHMP have a negative opinion also at reexamination.

Adding OLE and post hoc in-trial findings is not going fix what is likely fundamental issue with the RCT.